Advertisement

Topics

Proton pump inhibitors do not contribute to dementia or Alzheimer's disease

20:00 EDT 21 Jun 2017 | AAAS

(American Geriatrics Society) Noting that the prescription of proton pump inhibitors is on the rise among middle-aged and older adults, a team of researchers designed a new study to examine PPIs and the risk of dementia, mild cognitive impairment, and Alzheimer's disease. They published their study in the Journal of the American Geriatrics Society.

Original Article: Proton pump inhibitors do not contribute to dementia or Alzheimer's disease

NEXT ARTICLE

More From BioPortfolio on "Proton pump inhibitors do not contribute to dementia or Alzheimer's disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Dementia
Dementia describes a range of symptoms of cognitive decline. For example memory loss, problems with reasoning and communication skills, and a reduction in a person's abilities and skills in carrying out daily activities. There are about 820,000 peo...